Long-Term Risk for Device-Related Complications and Reoperations After Implantable Cardioverter-Defibrillator

Insights

Older adults receiving an implantable cardioverter-defibrillator (ICD) face significant risks of complications and reoperations. Careful consideration of ICD implantation benefits versus risks is crucial for patient care.

Area of Science:

  • Cardiology
  • Medical Devices
  • Health Outcomes Research

Background:

  • Long-term nonfatal outcomes following implantable cardioverter-defibrillator (ICD) placement are not well-defined.
  • Understanding these outcomes is critical for patient management and device selection.
  • The American College of Cardiology Foundation's National Cardiovascular Data Registry provides valuable data for such research.

Purpose of the Study:

  • To determine the long-term risk of ICD-related complications requiring reoperation or hospitalization.
  • To assess the risk of reoperation for reasons other than complications.
  • To identify patient and device characteristics associated with these risks.

Main Methods:

  • An observational cohort study utilized data from the National Cardiovascular Data Registry ICD registry linked with Medicare fee-for-service claims.
  • The study included 114,484 patients aged 65 years or older who received their first ICD between 2006 and 2010 across 1437 U.S. hospitals.
  • Outcomes assessed included ICD-related complications requiring reoperation/hospitalization and reoperations for other causes, with a median follow-up of 2.7 years.

Main Results:

  • The study found 6.1 ICD-related complications per 100 patient-years requiring reoperation or hospitalization and 3.9 reoperations per 100 patient-years for other reasons.
  • Younger age at implantation, receipt of a cardiac resynchronization therapy with a defibrillator (CRT-D) device, female sex, and black race were associated with increased risks.
  • Overall, 10 patients experienced complications or reoperation per 100 patient-years.

Conclusions:

  • Patients aged 65 and older have a high rate of device-related complications and reoperations after ICD implantation.
  • Factors such as younger age, CRT-D device type, female sex, and black race increase the risk of complications.
  • The risks associated with ICD implantation and strategies to mitigate them warrant active consideration prior to the procedure.
Abstract

Related Concept Videos

Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...